These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30943030)

  • 21. Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4/5 inhibitors and biological evaluation.
    Chen L; Zhang Z; Tian H; Jiang S; Ji Y; Liu M; Shen J; Cao Z; Wang K
    Bioorg Med Chem; 2022 Aug; 68():116853. PubMed ID: 35653869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1-Alkyl-2-(pyrrolidin-1-yl)-1H-benzo[d]imidazoles as Potent and Selective Inhibitors.
    Sharma S; L Pablo J; Tolentino KT; Gallegos W; Hinman J; Beninato M; Asche M; Greka A; Hopkins CR
    ChemMedChem; 2022 Jul; 17(14):e202200151. PubMed ID: 35557491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The first ankyrin-like repeat is the minimum indispensable key structure for functional assembly of homo- and heteromeric TRPC4/TRPC5 channels.
    Schindl R; Frischauf I; Kahr H; Fritsch R; Krenn M; Derndl A; Vales E; Muik M; Derler I; Groschner K; Romanin C
    Cell Calcium; 2008 Mar; 43(3):260-9. PubMed ID: 17624425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels.
    Jiang H; Zeng B; Chen GL; Bot D; Eastmond S; Elsenussi SE; Atkin SL; Boa AN; Xu SZ
    Biochem Pharmacol; 2012 Apr; 83(7):923-31. PubMed ID: 22285229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of automated patch clamp assays for canonical transient receptor potential channels TRPC3, 6, and 7.
    McPate M; Bhalay G; Beckett M; Fairbrother S; Gosling M; Groot-Kormelink PJ; Lane R; Kent T; Van Diepen MT; Tranter P; Verkuyl JM
    Assay Drug Dev Technol; 2014 Jun; 12(5):282-92. PubMed ID: 24906109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physiological and pathophysiological role of transient receptor potential canonical channels in cardiac myocytes.
    Ahmad AA; Streiff M; Hunter C; Hu Q; Sachse FB
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):254-263. PubMed ID: 28629808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for human TRPC5 channel inhibition by two distinct inhibitors.
    Song K; Wei M; Guo W; Quan L; Kang Y; Wu JX; Chen L
    Elife; 2021 Mar; 10():. PubMed ID: 33683200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of Zinc-Dependent Delayed Calcium Influx via TRPC5 in Oxidative Neuronal Death and its Prevention by Novel TRPC Antagonist.
    Park SE; Song JH; Hong C; Kim DE; Sul JW; Kim TY; Seo BR; So I; Kim SY; Bae DJ; Park MH; Lim HM; Baek IJ; Riccio A; Lee JY; Shim WH; Park B; Koh JY; Hwang JJ
    Mol Neurobiol; 2019 Apr; 56(4):2822-2835. PubMed ID: 30062674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and Characterization of a Specific Iodine-125-Labeled TRPC5 Radioligand.
    Yu Y; Liang Q; Du L; Jiang H; Gu J; Hu H; Tu Z
    ChemMedChem; 2020 Oct; 15(19):1854-1860. PubMed ID: 32717096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels.
    Plant TD; Schaefer M
    Cell Calcium; 2003; 33(5-6):441-50. PubMed ID: 12765689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site.
    Wright DJ; Simmons KJ; Johnson RM; Beech DJ; Muench SP; Bon RS
    Commun Biol; 2020 Nov; 3(1):704. PubMed ID: 33230284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-Ylidenephthalides as a new class of transient receptor potential channel TRPA1 and TRPM8 modulators.
    Ortar G; Schiano Moriello A; Morera E; Nalli M; Di Marzo V; De Petrocellis L
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5614-8. PubMed ID: 23993334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRPC5 is required for the NO-dependent increase in dendritic Ca
    Maddox JW; Khorsandi N; Gleason E
    J Neurophysiol; 2018 Jan; 119(1):262-273. PubMed ID: 28978766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sphingosine-1-phosphate induces Ca
    Shirakawa H; Katsumoto R; Iida S; Miyake T; Higuchi T; Nagashima T; Nagayasu K; Nakagawa T; Kaneko S
    Glia; 2017 Jun; 65(6):1005-1016. PubMed ID: 28300348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecules targeting canonical transient receptor potential channels: an update.
    Liu H; Fu M; Zhang Y; You Q; Wang L
    Drug Discov Today; 2024 May; 29(5):103951. PubMed ID: 38514041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPC Channels and Mental Disorders.
    Griesi-Oliveira K; Suzuki AM; Muotri AR
    Adv Exp Med Biol; 2017; 976():137-148. PubMed ID: 28508319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRPC Channels and Glioma.
    Li S; Ding X
    Adv Exp Med Biol; 2017; 976():157-165. PubMed ID: 28508321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of TRPC5 channels by intracellular ATP.
    Dattilo M; Penington NJ; Williams K
    Mol Pharmacol; 2008 Jan; 73(1):42-9. PubMed ID: 17925457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient receptor potential (TRP) channel function in the reproductive axis.
    Götz V; Qiao S; Beck A; Boehm U
    Cell Calcium; 2017 Nov; 67():138-147. PubMed ID: 28522036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.
    Ma R; Chaudhari S; Li W
    Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.